[Form 4] METLIFE INC Insider Trading Activity
MetLife director William E. Kennard reported an acquisition of 534 shares of MetLife common stock on 10/01/2025 at a reported price of $81.93 per share. After the transaction, the reporting person beneficially owned 44,452 shares. The filing notes these shares were part of non-management director compensation and that the director elected to defer receipt under the MetLife Deferred Compensation Plan for Non-Management Directors. Some shares are held indirectly through the MetLife Policyholder Trust, which holds shares allocated to eligible policyholders of a MetLife subsidiary.
Il direttore di MetLife William E. Kennard ha riportato l'acquisizione di 534 azioni ordinarie MetLife il 10/01/2025 a un prezzo riportato di $81.93 per azione. Dopo la transazione, la persona indicante beneficialmente deteneva 44,452 azioni. La nota nel modulo indica che queste azioni-facevano parte della compensazione per i direttori non esecutivi e che il direttore ha scelto di differire la ricezione ai sensi del MetLife Deferred Compensation Plan for Non-Management Directors. Alcune azioni sono detenute indirettamente tramite il MetLife Policyholder Trust, che detiene azioni assegnate agli assicurati idonei di una controllata di MetLife.
El director de MetLife, William E. Kennard, reportó la adquisición de 534 acciones comunes de MetLife el 10/01/2025 a un precio reportado de $81.93 por acción. Después de la operación, la persona que reporta poseía beneficiosamente 44,452 acciones. El archivo señala que estas acciones formaban parte de la compensación para directores no ejecutivos y que el director eligió diferir el recibo bajo el MetLife Deferred Compensation Plan for Non-Management Directors. Algunas acciones se mantienen indirectamente a través del MetLife Policyholder Trust, que posee acciones asignadas a asegurados elegibles de una subsidiaria de MetLife.
메트라이프 이사 William E. Kennard가 534주의 메트라이프 보통주를 2025-10-01에 매입했다고 보고했습니다. 주당 보고가격은 $81.93입니다. 거래 후 보고자는 44,452주를 실질적으로 보유하게 되었습니다. 보고서는 이 주식이 비경영진 이사 보상에 해당하며 이사는 MetLife Deferred Compensation Plan for Non-Management Directors에 따라 지급 수령을 연기하기로 선택했다고 명시합니다. 일부 주식은 MetLife Policyholder Trust를 통해 간접 보유되며, 이 신탁은 MetLife 자회사에 속한 적격 보험계약자에게 배정된 주식을 보유합니다.
Le directeur de MetLife, William E. Kennard, a déclaré l'acquisition de 534 actions ordinaires MetLife le 10/01/2025 à un prix déclaré de $81.93 par action. Après l'opération, la personne déclarant détenait bénéficairement 44 452 actions. Le dossier précise que ces actions faisaient partie de la rémunération des administrateurs non exécutifs et que le directeur a choisi de différer leur perception dans le cadre du MetLife Deferred Compensation Plan for Non-Management Directors. Certaines actions sont détenues indirectement par le MetLife Policyholder Trust, qui détient des actions attribuées aux titulaires de police admissibles d'une filiale de MetLife.
MetLife-Direktor William E. Kennard meldete den Erwerb von 534 MetLife-Stammaktien am 01.10.2025 zu einem angegebenen Preis von $81,93 pro Aktie. Nach der Transaktion besaß die meldende Person vorteilhaft 44.452 Aktien. Die Einreichung vermerkt, dass diese Aktien Teil der Vergütung von nicht-geschäftsführenden Direktoren waren und dass der Direktor die Abgabe unter dem MetLife Deferred Compensation Plan for Non-Management Directors aufgeschoben hat. Einige Aktien werden indirekt über den MetLife Policyholder Trust gehalten, der Aktien hält, die den berechtigten Versicherungsnehmern einer MetLife-Tochtergesellschaft zugeteilt sind.
أبلغ مدير ميتلايف ويليام إي. كينارد عن استحواذه على 534 سهماً من أسهم ميتلايف العادية في تاريخ 01/10/2025 بسعر مُعلن قدره $81.93 للسهم. بعد الصفقة، امتلك الشخص المُبلغ عنه فعلياً 44,452 سهماً. تشير الوثيقة إلى أن هذه الأسهم كانت جزءاً من تعويض المدراء غير التنفيذيين وأن المدير اختار تأجيل الاستلام بموجب MetLife Deferred Compensation Plan for Non-Management Directors. بعض الأسهم مملوكة بشكل غير مباشر من خلال MetLife Policyholder Trust، وهو صندوق يملك أسهماً مخصَّصة لملاك وثائق مؤهَّلين في شركة تابعة لـميتلايف.
MetLife 董事 William E. Kennard 于 2025/10/01 以每股 $81.93 的报价购买了 534 股 MetLife 普通股。交易完成后，申报人实际持有 44,452 股。文件指出这些股票属于非管理层董事报酬的一部分，董事选择按照 MetLife Deferred Compensation Plan for Non-Management Directors 推迟领取。一些股票通过 MetLife Policyholder Trust 间接持有，该信托持有分配给 MetLife 子公司合格保单持有人的股票。
- Director purchase/deferral of 534 shares increases insider alignment with shareholders
- Total beneficial ownership of 44,452 shares indicates continued insider stake
- None.
Insights
Director defers compensation into company stock, modestly increasing ownership.
This Form 4 discloses a non-management director received 534 shares as part of compensation and deferred them under the director deferred compensation plan, aligning pay with shareholder equity.
The director's total reported beneficial ownership is 44,452 shares, and part of the holding is indirect via the MetLife Policyholder Trust. This is a routine, disclosed governance practice rather than a directional market signal.
Il direttore di MetLife William E. Kennard ha riportato l'acquisizione di 534 azioni ordinarie MetLife il 10/01/2025 a un prezzo riportato di $81.93 per azione. Dopo la transazione, la persona indicante beneficialmente deteneva 44,452 azioni. La nota nel modulo indica che queste azioni-facevano parte della compensazione per i direttori non esecutivi e che il direttore ha scelto di differire la ricezione ai sensi del MetLife Deferred Compensation Plan for Non-Management Directors. Alcune azioni sono detenute indirettamente tramite il MetLife Policyholder Trust, che detiene azioni assegnate agli assicurati idonei di una controllata di MetLife.
El director de MetLife, William E. Kennard, reportó la adquisición de 534 acciones comunes de MetLife el 10/01/2025 a un precio reportado de $81.93 por acción. Después de la operación, la persona que reporta poseía beneficiosamente 44,452 acciones. El archivo señala que estas acciones formaban parte de la compensación para directores no ejecutivos y que el director eligió diferir el recibo bajo el MetLife Deferred Compensation Plan for Non-Management Directors. Algunas acciones se mantienen indirectamente a través del MetLife Policyholder Trust, que posee acciones asignadas a asegurados elegibles de una subsidiaria de MetLife.
메트라이프 이사 William E. Kennard가 534주의 메트라이프 보통주를 2025-10-01에 매입했다고 보고했습니다. 주당 보고가격은 $81.93입니다. 거래 후 보고자는 44,452주를 실질적으로 보유하게 되었습니다. 보고서는 이 주식이 비경영진 이사 보상에 해당하며 이사는 MetLife Deferred Compensation Plan for Non-Management Directors에 따라 지급 수령을 연기하기로 선택했다고 명시합니다. 일부 주식은 MetLife Policyholder Trust를 통해 간접 보유되며, 이 신탁은 MetLife 자회사에 속한 적격 보험계약자에게 배정된 주식을 보유합니다.
Le directeur de MetLife, William E. Kennard, a déclaré l'acquisition de 534 actions ordinaires MetLife le 10/01/2025 à un prix déclaré de $81.93 par action. Après l'opération, la personne déclarant détenait bénéficairement 44 452 actions. Le dossier précise que ces actions faisaient partie de la rémunération des administrateurs non exécutifs et que le directeur a choisi de différer leur perception dans le cadre du MetLife Deferred Compensation Plan for Non-Management Directors. Certaines actions sont détenues indirectement par le MetLife Policyholder Trust, qui détient des actions attribuées aux titulaires de police admissibles d'une filiale de MetLife.
MetLife-Direktor William E. Kennard meldete den Erwerb von 534 MetLife-Stammaktien am 01.10.2025 zu einem angegebenen Preis von $81,93 pro Aktie. Nach der Transaktion besaß die meldende Person vorteilhaft 44.452 Aktien. Die Einreichung vermerkt, dass diese Aktien Teil der Vergütung von nicht-geschäftsführenden Direktoren waren und dass der Direktor die Abgabe unter dem MetLife Deferred Compensation Plan for Non-Management Directors aufgeschoben hat. Einige Aktien werden indirekt über den MetLife Policyholder Trust gehalten, der Aktien hält, die den berechtigten Versicherungsnehmern einer MetLife-Tochtergesellschaft zugeteilt sind.
FAQ
What did MetLife director William E. Kennard report on Form 4 (MET)?
Why were the shares issued to the director?
Are any of the reported shares held indirectly?
Does this Form 4 indicate a sale or reduction in holdings?
When was the Form 4 signed?
